Pfizer 400 Pill - orange oval, 18mm
Generic Name: bosutinib
Pill with imprint Pfizer 400 is Orange, Oval and has been identified as Bosulif 400 mg. It is supplied by Pfizer Inc.
Bosulif is used in the treatment of Chronic Myelogenous Leukemia and belongs to the drug class BCR-ABL tyrosine kinase inhibitors. There is positive evidence of human fetal risk during pregnancy. Bosulif 400 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer 400
Bosulif
- Generic Name
- bosutinib
- Imprint
- Pfizer 400
- Strength
- 400 mg
- Color
- Orange
- Size
- 18.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- BCR-ABL tyrosine kinase inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0193
- Inactive Ingredients
-
microcrystalline cellulose,
croscarmellose sodium,
povidone k25,
magnesium stearate,
titanium dioxide,
polyethylene glycol 3350,
magnesium silicate,
ferric oxide red,
poloxamer 188
Note: Inactive ingredients may vary.
See also:
Hydrea
Hydrea is used for chronic myelogenous leukemia, head and neck cancer
Sprycel
Sprycel is used to treat chronic myeloid leukemia and acute lymphoblastic leukemia. Learn about ...
Botox
Botox is used for cosmetic purposes and to treat overactive bladder symptoms, urinary incontinence ...
Gleevec
Gleevec is targeted cancer therapy for specific types of leukemia (blood cancer), bone marrow ...
Cytoxan
Cytoxan is used for acute lymphocytic leukemia, acute nonlymphocytic leukemia, breast cancer ...
Tasigna
Tasigna (nilotinib) is used to treat Philadelphia chromosome positive chronic myeloid leukemia ...
Scemblix
Scemblix (asciminib) is an oral kinase inhibitor that may be used to treat adults with a type of ...
Iclusig
Iclusig (ponatinib) used to treat a type of blood cancer called chronic myeloid leukemia (CML), or ...
More about Bosulif (bosutinib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (7)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: BCR-ABL tyrosine kinase inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.